Hassan I, et al. - Due to endemic hepatitis B (HBV) infection and recent hepatitis C (HCV) and obesity epidemics, hepatocellular carcinoma (HCC) is now the fastest growing cause of cancer mortality in New Zealand. Thus, researchers analyzed survival in patients with HCC related to chronic HCV and HBV but not in those related to non-alcoholic steatohepatitis (NASH) or alcoholic liver disease (ALD). They assessed all newly diagnosed cases of HCC referred to NZLTU between 1998 and 2017. According to results, HCC diagnostic rates increased from 24 cases in 1998 to 250 in 2017—a 20% increase per year. Better results in HBV-related or HCV-related HCC patients than those with NASH-related or ALD-related HCV might reflect better screening uptake and better access to curative therapies.